Literature DB >> 7044976

Phage influence on the synthesis of extracellular toxins in group A streptococci.

S K Nida, J J Ferretti.   

Abstract

Phage conversion of group A streptococci to produce streptococcal exotoxins was shown to occur more widely than has been previously reported. Toxigenic conversion was found in 19 newly constructed lysogenic and pseudolysogenic strains resulting in synthesis of exotoxin types A and B. Conversion was accomplished by a positive conversion effector, which was a phage characteristic expressed by the prophage and vegetatively reproducing phage. Exotoxin production was determined by the rabbit skin test and by countercurrent immunoelectrophoresis with type-specific antisera. New lysogens and pseudolysogens were constructed with strains which failed to produce at least one exotoxin type. Phages were obtained from toxigenic strains isolated from cases of scarlet fever. Conversions were consistent and repeatable; loss of the recently introduced phage was accompanied by loss of the newly acquired toxin productivity. Conversion resulted in production of additional exotoxin type or types and never affected existing toxin synthesis. Converting phages were characterized by electron microscopy and negatively stained preparations and were all found to be of morphological class B1. All phage nucleic acid was double-stranded DNA. Though similar in structure, each converting phage had a different host range, and the nine new converting phages identified here did not react with antiserum prepared against the originally reported converting phage.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7044976      PMCID: PMC351293          DOI: 10.1128/iai.36.2.745-750.1982

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  18 in total

Review 1.  Developmental pathways for the temperate phage: lysis vs lysogeny,.

Authors:  H Echols
Journal:  Annu Rev Genet       Date:  1972       Impact factor: 16.830

2.  A manual of quantitative immunoelectrophoresis. Methods and applications. 1. General remarks on principles, equipment, reagents and procedures.

Authors:  B Weeke
Journal:  Scand J Immunol Suppl       Date:  1973

3.  Characterization of bacteriophages from nephritogenic group A streptococci.

Authors:  L W Wannamaker; S Skjold; W R Maxted
Journal:  J Infect Dis       Date:  1970-04       Impact factor: 5.226

4.  Host-cell reactivation of ultraviolet-damaged phage in Streptococcus pyogenes.

Authors:  H Malke
Journal:  Biochem Biophys Res Commun       Date:  1967-11-17       Impact factor: 3.575

Review 5.  Ultrastructure of bacteriophage and bacteriocins.

Authors:  D E Bradley
Journal:  Bacteriol Rev       Date:  1967-12

Review 6.  Persisting bacteriophage infections, lysogeny, and phage conversions.

Authors:  L Barksdale; S B Arden
Journal:  Annu Rev Microbiol       Date:  1974       Impact factor: 15.500

7.  The fluorescent staining of bacteriophage nucleic acids.

Authors:  D E Bradley
Journal:  J Gen Microbiol       Date:  1966-09

8.  Group A streptococcal pyrogenic exotoxin: pyrogenicity, alteration of blood-brain barrier, and separation of sites for pyrogenicity and enhancement of lethal endotoxin shock.

Authors:  P M Schlievert; D W Watson
Journal:  Infect Immun       Date:  1978-09       Impact factor: 3.441

9.  A purified group A streptococcal pyrogenic exotoxin. Physiochemical and biological properties including the enhancement of susceptibility to endotoxin lethal shock.

Authors:  Y B Kim; D W Watson
Journal:  J Exp Med       Date:  1970-03-01       Impact factor: 14.307

10.  Intergroup phage reactions and transduction between group C and group A streptococci.

Authors:  L W Wannamaker; S Almquist; S Skjold
Journal:  J Exp Med       Date:  1973-06-01       Impact factor: 14.307

View more
  14 in total

1.  Do streptococci cause toxic shock?

Authors:  P Sanderson
Journal:  BMJ       Date:  1990-11-03

2.  Identification and characterization of bicistronic speB and prsA gene expression in the group A Streptococcus.

Authors:  Yongsheng Ma; Amy E Bryant; Dan B Salmi; Susan M Hayes-Schroer; Eric McIndoo; Michael J Aldape; Dennis L Stevens
Journal:  J Bacteriol       Date:  2006-09-01       Impact factor: 3.490

3.  Molecular characterization of new group A streptococcal bacteriophages containing the gene for streptococcal erythrogenic toxin A (speA).

Authors:  C E Yu; J J Ferretti
Journal:  Mol Gen Genet       Date:  1991-12

4.  Frequency of the erythrogenic toxin B and C genes (speB and speC) among clinical isolates of group A streptococci.

Authors:  C E Yu; J J Ferretti
Journal:  Infect Immun       Date:  1991-01       Impact factor: 3.441

5.  Bacteriophage involvement in group A streptococcal pyrogenic exotoxin A production.

Authors:  L P Johnson; M A Tomai; P M Schlievert
Journal:  J Bacteriol       Date:  1986-05       Impact factor: 3.490

6.  A physical map of the group A streptococcal pyrogenic exotoxin bacteriophage T12 genome.

Authors:  L P Johnson; P M Schlievert
Journal:  Mol Gen Genet       Date:  1983

7.  Cloning and characterization of bacteriophage-like DNA from Haemophilus somnus homologous to phages P2 and HP1.

Authors:  R A Pontarollo; C R Rioux; A A Potter
Journal:  J Bacteriol       Date:  1997-03       Impact factor: 3.490

8.  The gene for type A streptococcal exotoxin (erythrogenic toxin) is located in bacteriophage T12.

Authors:  C R Weeks; J J Ferretti
Journal:  Infect Immun       Date:  1984-11       Impact factor: 3.441

9.  Growth characteristics of Bartonella henselae in a novel liquid medium: primary isolation, growth-phase-dependent phage induction, and metabolic studies.

Authors:  M R Chenoweth; G A Somerville; D C Krause; K L O'Reilly; F C Gherardini
Journal:  Appl Environ Microbiol       Date:  2004-02       Impact factor: 4.792

10.  Prophage induction and expression of prophage-encoded virulence factors in group A Streptococcus serotype M3 strain MGAS315.

Authors:  David J Banks; Benfang Lei; James M Musser
Journal:  Infect Immun       Date:  2003-12       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.